Potential cost-savings may be considerable with management of hypertension according to updated US hypertension guidelines, but for women aged 35-44 years these benefits are unlikely

Evid Based Med. 2015 Aug;20(4):150. doi: 10.1136/ebmed-2015-110202. Epub 2015 Jun 9.
No abstract available

Keywords: CARDIOLOGY; HEALTH ECONOMICS; PUBLIC HEALTH.

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents / economics*
  • Cardiovascular Diseases / prevention & control*
  • Cost-Benefit Analysis*
  • Female
  • Humans
  • Hypertension / economics*
  • Male
  • Practice Guidelines as Topic*
  • Quality-Adjusted Life Years*

Substances

  • Antihypertensive Agents